UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets

Diabetic medicine, 2007-10, Vol.24 (10), p.1112-1120

2007

Volltextzugriff (PDF)

The Health Technology Assessment-disease management instrument reliably measured methodologic quality of health technology assessments of disease management

Journal of clinical epidemiology, 2004-09, Vol.57 (9), p.881-888

2004

Volltextzugriff (PDF)

Identifying potentially cost effective chronic care programs for people with COPD

International journal of chronic obstructive pulmonary disease, 2009, Vol.4 (default), p.87-100

2009

Volltextzugriff (PDF)

Primary Treatments for Intermediate-Risk Prostate Cancer: a Cost-Effectiveness and Value-of-Information Analysis

Value in health, 2014-11, Vol.17 (7), p.A323-A323

2014

Volltextzugriff (PDF)

Economic evaluation of nurse practitioners versus GPs in treating common conditions

British journal of general practice, 2010-01, Vol.60 (570), p.e28-e35

2010

Volltextzugriff (PDF)

Budget Impact Analysis of a Return-To-Work Intervention for Cancer Patients Shows Hospitals Bear the Costs, for Society to Enjoy the Benefits

Value in health, 2014-11, Vol.17 (7), p.A624-A624

2014

Volltextzugriff (PDF)

Combining Headroom and Return on Investment Analysis To Rank Potential Commercial Value of Six Medical Devices in Development

Value in health, 2014-11, Vol.17 (7), p.A443-A443

2014

Volltextzugriff (PDF)

Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy

Value in health, 2014-11, Vol.17 (7), p.A323-A323

2014

Volltextzugriff (PDF)

Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

Value in health, 2014-11, Vol.17 (7), p.A644-A644

2014

Volltextzugriff (PDF)

Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

Value in health, 2014-11, Vol.17 (7), p.A640-A640

2014

Volltextzugriff (PDF)

Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure (the TEHAF-study)

European heart journal, 2013-08, Vol.34 (suppl 1), p.P3346-P3346

2013

Volltextzugriff (PDF)

Cost-minimisation in vitamin B12 deficiencies: expensive diagnostics can reduce spending

Netherlands journal of medicine, 2013-06, Vol.71 (5), p.274-275

2013

Volltextzugriff (PDF)

An Open Letter in Support of Transformative Biotechnology and Social Innovation: SANKO University Innovation Summit in Medicine and Integrative Biology, Gaziantep, Turkey, May 5-7, 2016

Omics (Larchmont, N.Y.), 2016-04, Vol.20 (4), p.259-262

2016

Volltextzugriff (PDF)

Quick remedies for improving diabetes care: A contradiction in terms

Primary care diabetes, 2007-12, Vol.1 (4), p.213-214

2007

Volltextzugriff (PDF)

Return on Investment van disease management programma’s

TSG : tijdschrift voor gezondheidswetenschappen, 2008-05, Vol.86 (5), p.231-233

2008

Volltextzugriff (PDF)

Participation of general practitioners in disease management: experiences from The Netherlands

International journal of integrated care, 2002-03, Vol.2 (1), p.e24-e24

2002

Volltextzugriff (PDF)

427P Oncology combination therapies in Asia-Pacific markets: What are the current access challenges?

Annals of oncology, 2022-11, Vol.33, p.S1607

2022

Volltextzugriff (PDF)

PIN62 Recognising the broader value of vaccines in HTA: ready for prime time?

Value in health, 2021-06, Vol.24, p.S117-S117

2021

Volltextzugriff (PDF)

HTA156 Health Technology Assessment of Multiple Myeloma Therapies: Value Demonstration and Value Recognition Challenges

Value in health, 2023-12, Vol.26 (12), p.S348-S349

2023

Volltextzugriff (PDF)

HTA1 Adaptive Pathways for Tumour Agnostic Medicines in Various Developed Markets

Value in health, 2020-12, Vol.23, p.S402-S402

2020

Volltextzugriff (PDF)

Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102

JCO oncology practice, 2024-04, Vol.20 (4), p.572-580

2024

Volltextzugriff (PDF)

Integrating health economics modeling in the product development cycle of medical devices: A Bayesian approach

International journal of technology assessment in health care, 2008-10, Vol.24 (4), p.459-464

2008

Volltextzugriff (PDF)

HTA180 The Value-Generation-Value-Recognition Gap for Novel Gene Therapies in European HTA Systems Using X-Linked Retinitis Pigmentosa as a Case Study

Value in health, 2022-12, Vol.25 (12), p.S331-S331

2022

Volltextzugriff (PDF)

EE351 Recognising the Broader Value of Meningococcal Vaccination: A Matter of Evidence, Ability or Willingness?

Value in health, 2022-12, Vol.25 (12), p.S123-S124

2022

Volltextzugriff (PDF)

PMU13 COST-EFFECTIVENESS ANALYSIS OF PCT-GUIDED ANTIBIOTIC STEWARDSHIP FOR HOSPITALIZED PATIENTS WITH SEPSIS OR LOWER RESPIRATORY TRACT INFECTIONS IN A US HOSPITAL

Value in health, 2019-11, Vol.22, p.S710-S710

2019

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(53)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets

The Health Technology Assessment-disease management instrument reliably measured methodologic quality of health technology assessments of disease management

Identifying potentially cost effective chronic care programs for people with COPD

Primary Treatments for Intermediate-Risk Prostate Cancer: a Cost-Effectiveness and Value-of-Information Analysis

Economic evaluation of nurse practitioners versus GPs in treating common conditions

Budget Impact Analysis of a Return-To-Work Intervention for Cancer Patients Shows Hospitals Bear the Costs, for Society to Enjoy the Benefits

Combining Headroom and Return on Investment Analysis To Rank Potential Commercial Value of Six Medical Devices in Development

Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy

Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure (the TEHAF-study)

Cost-minimisation in vitamin B12 deficiencies: expensive diagnostics can reduce spending

An Open Letter in Support of Transformative Biotechnology and Social Innovation: SANKO University Innovation Summit in Medicine and Integrative Biology, Gaziantep, Turkey, May 5-7, 2016

Quick remedies for improving diabetes care: A contradiction in terms

Return on Investment van disease management programma’s

Participation of general practitioners in disease management: experiences from The Netherlands

427P Oncology combination therapies in Asia-Pacific markets: What are the current access challenges?

PIN62 Recognising the broader value of vaccines in HTA: ready for prime time?

HTA156 Health Technology Assessment of Multiple Myeloma Therapies: Value Demonstration and Value Recognition Challenges

HTA1 Adaptive Pathways for Tumour Agnostic Medicines in Various Developed Markets

Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102

Integrating health economics modeling in the product development cycle of medical devices: A Bayesian approach

HTA180 The Value-Generation-Value-Recognition Gap for Novel Gene Therapies in European HTA Systems Using X-Linked Retinitis Pigmentosa as a Case Study

EE351 Recognising the Broader Value of Meningococcal Vaccination: A Matter of Evidence, Ability or Willingness?

PMU13 COST-EFFECTIVENESS ANALYSIS OF PCT-GUIDED ANTIBIOTIC STEWARDSHIP FOR HOSPITALIZED PATIENTS WITH SEPSIS OR LOWER RESPIRATORY TRACT INFECTIONS IN A US HOSPITAL

Suchergebnisse filtern